Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Heron Therapeutics, Inc. (HRTX) Institutional Ownership & Insider Trading

161 institutions reported holding Heron Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

HRTXHeron Therapeutics, Inc.Follow HRTX — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
57.5M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
10 Nov, in 17 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

161 institutions held 70.4% of the shares. Across filers that reported both quarters, shares held changed -15.4%.

Increased+50New+18Decreased-35Closed-20

Largest moves, shares (millions)

Marshall Wace+2.4MQube Research & Technologies+1.0MGsa Capital Partners+0.9MOrbimed Advisors-9.8MPalisade Capital Management-6.1MMillennium Management-3.6M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-8.8Sep 24-7.1Dec 24+9.8Mar 25+6.8Jun 25+22.5Sep 25-0.5Dec 25+0.5Mar 26-23.9Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26161134-15.4%50183520
Mar 26166157+0.3%50243928
Dec 25167156-0.3%48184023
Sep 25169154+17.1%49154814
Jun 25170131+5.4%57202813
Mar 25164125+8.6%47224215
Dec 24161115-6.2%37204533
Sep 24171122-7.2%61173636

Heron Therapeutics, Inc. — questions

Who owns Heron Therapeutics, Inc. stock?
161 institutions reported Heron Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Rubric Capital Management LP (15.8%), Clearline Capital LP (6.0%), BlackRock, Inc. (5.6%).

Every figure on this page comes from Heron Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.